acquired
Stage
About
Sirtris was a biopharmaceutical company focused on drug development based on sirtuin enzymes, targeting diseases associated with aging such as Type 2 Diabetes. It went public in 2006 and was acquired by GlaxoSmithKline in 2007.
Explore Sirtris's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.